Disclosed are a phthalic hydrazide (phthalazine ketone) compound, and a pharmaceutical composition comprising the same. As a DNA repair enzyme poly (ADP-ribozyme) polymerase inhibitor, the compound and the pharmaceutical composition can effectively treat diseases involving PARP enzymatic activity, including cancer, neural degenerative diseases, inflammation and the like.
揭示了一种邻苯二甲酰
肼(邻苯二酮)化合物,以及包含该化合物的药物组合物。作为DNA修复酶聚(
ADP-
核糖酶)聚合酶
抑制剂,该化合物和药物组合物可以有效治疗涉及PARP酶活性的疾病,包括癌症、神经退行性疾病、炎症等。